4

4 Filing

Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed: February 4, 2016
Period of Report: February 4, 2016
Accession Number: 0001493152-16-007181

View Document ↗ View on SEC.gov ↗